Evidence map›Paper›PMID 24404017›Full record

ArticleBiomicrofluidics2013

Protein sensing by nanofluidic crystal and its signal enhancement.

Jianming Sang, Hongtan Du, Wei Wang, Ming Chu, Yuedan Wang, Haichao Li, Haixia Alice Zhang, Wengang Wu, Zhihong Li

Abstract read
In one paragraph

Article in Biomicrofluidics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jianming SangInstitute of Microelectronics, Peking University, Beijing, 100871, China ; School of Basic Medical Sciences, Peking University, Beijing, 100871, China.
Hongtan DuInstitute of Microelectronics, Peking University, Beijing, 100871, China.
Wei WangInstitute of Microelectronics, Peking University, Beijing, 100871, China ; National Key Laboratory of Science and Technology on Micro/Nano Fabrication, Beijing, 100871, China.
Ming ChuSchool of Basic Medical Sciences, Peking University, Beijing, 100871, China.
Yuedan WangSchool of Basic Medical Sciences, Peking University, Beijing, 100871, China.
Haichao LiPeking University First Hospital, Peking University, Beijing, 100034, China.
Haixia Alice ZhangInstitute of Microelectronics, Peking University, Beijing, 100871, China ; National Key Laboratory of Science and Technology on Micro/Nano Fabrication, Beijing, 100871, China.
Wengang WuInstitute of Microelectronics, Peking University, Beijing, 100871, China ; National Key Laboratory of Science and Technology on Micro/Nano Fabrication, Beijing, 100871, China.
Zhihong LiInstitute of Microelectronics, Peking University, Beijing, 100871, China ; National Key Laboratory of Science and Technology on Micro/Nano Fabrication, Beijing, 100871, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanofluidics has a unique property that ionic conductance across a nanometer-sized confined space is strongly affected by the space surface charge density, which can be utilized to construct electrical read-out biosensor. Based on this principle, this work demonstrated a novel protein sensor along with a sandwich signal enhancement approach. Nanoparticles with designed aptamer onside are assembled in a suspended micropore to form a 3-dimensional network of nanometer-sized interstices, named as nanofluidic crystal hereafter, as the basic sensing unit. Proteins captured by aptamers will change the surface charge density of nanoparticles and thereby can be detected by monitoring the ionic conductance across this nanofluidic crystal. Another aptamer can further enlarge the variations of the surface charge density by forming a sandwich structure (capturing aptamer/protein/signal enhancement aptamer) and the read-out conductance as well. The preliminary experimental results indicated that human α-thrombin was successfully detected by the corresponding aptamer modified nanofluidic crystal with the limit of detection of 5 nM (0.18 μg/ml) and the read-out signal was enhanced up to 3 folds by using another thrombin aptamer. Being easy to graft probe, facile and low-cost to prepare the nano-device, and having an electrical read-out, the present nanofluidic crystal scheme is a promising and universal strategy for protein sensing.

Identifiers

PMID24404017
PMCPMC3651251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.